Mechanism of action EIDD-2801 is an orally bioavailable isopropyl ester precursor of the ribonucleoside analogue EIDD-1931 (N4-hydroxycytidine). It is hydrolyzed in vivo and distributed to tissues, where it becomes the active form of 5'-triphosphate. The active drug is incorporated into the genome of RNA viruses, leading to an accumulation of mutations known as viral error catastrophe. Recent studies have shown that EIDD-2801 inhibits the replication of... Continue reading EIDD-2801 (Molnupiravir)
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed